Amphastar Pharma (AMPH) Tops Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amphastar Pharma (AMPH) Tops Q4 EPS by 2c

Amphastar Pharmaceuticals (AMPH) PT Raised to $23 at BMO Capital

March 13, 2019 6:36 AM EDT

BMO Capital analyst Gary Nachman raised the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $23.00 (from $21.00) while maintaining a Market Perform rating.

4Q18 results were good overall, although the quarter did benefit from a couple of one-timers (Enoxaparin and insulin API).Management... More